Instil Bio
Stock Forecast, Prediction & Price Target
Instil Bio Financial Estimates
Instil Bio Revenue Estimates
Instil Bio EBITDA Estimates
Instil Bio Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $26.5M Low: $26.5M High: $26.5M avg. 0% | Avg: $15.53M Low: $15.53M High: $15.53M avg. -41.39% | Avg: $0 Low: $0 High: $0 avg. -100% | |
Net Income
% change YoY
| $-156.79M N/A | $-223.17M -42.33% | $-156.08M 30.06% | Avg: $-52.67M Low: $-95.34M High: $-2.79M avg. 66.25% | Avg: $-11.7M Low: $-3.57M High: $-3.57M avg. 77.78% | Avg: $-46.82M Low: $-46.82M High: $-46.82M avg. -300.24% | |
EBITDA
% change YoY
| $-155.56M N/A | $-200.2M -28.69% | $-146.12M 27.01% | Avg: $15.9M Low: $15.9M High: $15.9M avg. 110.88% | Avg: $9.31M Low: $9.31M High: $9.31M avg. -41.39% | Avg: $0 Low: $0 High: $0 avg. -100% | |
EPS
% change YoY
| -$24.3 N/A | -$34.46 -41.81% | -$24 30.35% | Avg: -$9.88 Low: -$14.66 High: -$0.43 avg. 58.84% | Avg: -$0.55 Low: -$0.55 High: -$0.55 avg. 94.43% | Avg: -$7.2 Low: -$7.2 High: -$7.2 avg. -1209.09% | |
Operating Expenses
% change YoY
| $155.56M N/A | $203.29M 30.68% | $85.78M -57.80% | Avg: $573.59M Low: $573.59M High: $573.59M avg. 568.63% | Avg: $336.14M Low: $336.14M High: $336.14M avg. -41.39% | Avg: $0 Low: $0 High: $0 avg. -100% | |
FAQ
What is Instil Bio stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -52.06% in 2025-2027.
We have gathered data from 2 analysts. Their low estimate is -95.34M, average is -52.67M and high is -2.79M.
What is Instil Bio stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -13.79% in 2025-2027.
We have gathered data from 3 analysts. Their low revenue estimate is $26.5M, average is $26.5M and high is $26.5M.
What is Instil Bio stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -351.93% in 2025-2027.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$14.66, average is -$9.88 and high is $-0.43.
What is the best performing analyst?
In the last twelve months analysts have been covering Instil Bio stock. The most successful analyst is Kelly Shi whose win rate is 100%. He has correctly predicted 1/1 price targets.